pharmaceutical-market
FinanceExclusive-Novo's Wegovy and Ozempic US advertising spend doubles rival Eli Lilly, data shows
FinanceAnalysis- Drugmakers brace for Europe pricing fight after Trump's US price-cut deals
FinanceUK's pharma regulator could issue a decision for Novo's Wegovy pill by year-end
HeadlinesNovo's Wegovy pill to test demand from consumers with cash
Roche CEO points to higher future drug prices in Switzerland after US deal
Date: December 20, 2025
ZURICH, Dec 20 (Reuters) - Deals between pharmaceutical companies and Washington to reduce prices for medicines in the United States will likely push up the cost of new drugs in Switzerland, the CEO...
Novartis, Roche back US efforts to lower drug costs amid talk of pricing deal
Date: December 18, 2025
ZURICH, Dec 18 (Reuters) - Swiss pharma giants Novartis and Roche on Thursday backed U.S. efforts to lower the cost of drugs and are working with the Trump administration towards that goal following a...
Exclusive-US FDA launches fresh safety scrutiny of approved RSV therapies for infants
Date: December 9, 2025
By Dan Levine and Patrick Wingrove Dec 9 (Reuters) - U.S. health regulators informed senior executives at Merck, Sanofi and AstraZeneca last week that their approved protective RSV treatments for...
Swiss economy contracts slightly in Q3 due to lower pharma exports
Date: November 28, 2025
ZURICH (Reuters) -Switzerland's economy contracted by 0.5% in the third quarter when adjusted for sporting events, driven by lower exports in the chemical and pharmaceutical industry, the economy...
US Medicare price cuts manageable for most drugmakers, analysts say
Date: November 26, 2025
LONDON (Reuters) -Novo Nordisk shares rose 5% on Wednesday after analysts said that U.S. price cuts for the Danish drugmaker's semaglutide came in broadly as expected. Late on Tuesday, the U.S....
Novo Nordisk chair touts OTC future for Wegovy as top investor tightens grip
Date: November 14, 2025
By Jacob Gronholt-Pedersen and Stine Jacobsen COPENHAGEN (Reuters) -Novo Nordisk's top shareholder forced through an overhaul of the Wegovy-maker's board at an extraordinary shareholder meeting on...